查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1857634

NGS樣品製備市場按產品類型、應用、技術、工作流程步驟和最終用戶分類－全球預測，2025-2032年

NGS Sample Preparation Market by Product Type, Application, Technology, Workflow Step, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，NGS 樣品製備市場將成長至 94.5 億美元，複合年成長率為 16.52%。

關鍵市場統計數據
基準年 2024 27.8億美元
預計年份：2025年 32.4億美元
預測年份 2032 94.5億美元
複合年成長率 (%) 16.52%

闡明為何最佳化次世代定序儀的樣本製備是一項能夠提升資料品質、工作流程效率和增強競爭優勢的策略能力。

次世代定序儀樣本製備是一項基礎性技術，它決定了研究、臨床和工業應用中數據的完整性、週轉速度和下游分析的準確性。過去十年，試劑、工作流程和自動化技術的不斷改進，持續縮短了定序週期，並擴展了其應用範圍，從標靶定序到全基因組和元基因組分析。在此背景下，樣品製備不再是常規的上游工序，而是一項策略性能力，對整個定序計畫的通量、可重複性和成本效益有顯著影響。

解釋正在重塑各實驗室樣品製備工作流程和供應商優先事項的技術、操作和應用主導轉變。

次世代定序儀的樣本製備格局正經歷多重變革，這些變革的驅動力包括技術創新、終端用戶需求的變化以及監管環境的調整。酵素工程和化學領域的進步使得片段化和文庫建構化學方法能夠可靠地處理低起始量、劣化和保存的樣本；而微流體和液滴技術則為常規工作流程帶來了小型化和並行化。這些技術變革與日益成長的自動化和封閉式系統解決方案的重視相輔相成，這些解決方案能夠減少操作人員的差異，並加快結果的獲取速度，尤其對於尋求提高診斷通量的臨床實驗室而言。

分析隨著美國關稅變化和貿易政策調整，供應鏈摩擦、採購複雜性和區域韌性如何成為2025年更重要的優先事項。

2025年美國關稅和貿易政策調整的累積效應，為樣品製備試劑、塑膠和儀器的全球供應鏈帶來了新的摩擦。更高的進口關稅和更嚴格的分類要求增加了部分硬體組件和特殊耗材的到岸成本，迫使採購團隊必須尋求供應商多元化，重新評估庫存策略和合約條款。同時，海關合規要求也要求更詳細的產品編碼和文件記錄，這不僅延長了關鍵產品的前置作業時間，還增加了供應商和買家的行政成本。

建立多軸細分框架，將產品類型、應用、技術、工作流程步驟和最終用戶畫像與策略性產品和商業化選擇連結起來。

一個連貫的細分框架揭示了樣本製備領域的多維特性，並闡明了創新與需求的交會點。從產品類型來看，市場涵蓋擴增試劑盒、片段化和大小選擇解決方案、文庫建構試劑盒以及標靶富集試劑盒。擴增試劑盒包括傳統PCR方法、數位PCR和qPCR，以及使用鎖定探針的滾環擴增和基於phi29的方法。片段化和大小選擇策略分為酵素片段化（區分內切酶和轉座酶方法）和機械片段化方法，例如常用的超音波平台。文庫建構提供RNA特異性工作流程（包括mRNA、小RNA和總RNA試劑盒）、針對遺傳疾病和腫瘤panel的標靶文庫建構方法，以及從無PCR到標準全基因組定序(WGS)建構的各種全基因組文庫建構試劑盒。標靶富集分為基於擴增子的方法（包括多重和單重 PCR）和雜合反應捕獲策略（利用陣列或溶液形式）。

探討區域供應鏈架構、管理體制和終端用戶成熟度將如何影響產品採用、支援模式和商業化策略。

區域動態將對樣品製備技術的應用、監管和商業化產生決定性影響。美洲擁有強大的學術研究能力和密集的診斷實驗室網路，這推動了對高通量自動化技術和支援臨床驗證的專用試劑盒的需求。轉化研究的投資以及成熟的私人生物技術產業獎勵供應商提供整合解決方案，以簡化監管申報和實驗室認證流程。此外，靠近主要製造商和區域分銷中心通常可以縮短前置作業時間並改善售後服務。

透過專有化學技術、自動化相容性、服務模式以及供應商之間的策略夥伴關係關係來評估競爭差異化

活躍於樣品製備領域的公司之間的競爭動態，體現在深厚的技術實力、廣泛的檢驗工作流程以及為客戶提供全生命週期服務的能力之間。領先企業透過專有化學技術、自動化整合和品管解決方案來降低變異性並加速驗證，從而實現差異化。試劑供應商和儀器製造商之間的夥伴關係日益普遍，以創造出捆綁式解決方案，簡化了高通量臨床和商業定序實驗室的採購流程。同時，規模較小的專業公司則專注於特定領域的化學技術，例如針對低起始量或受損DNA最佳化的酵素製劑，或能夠實現獨特樣品處理功能的微流體系統。

為採購、研發和實驗室負責人處方箋措施，以加強供應鏈韌性、加快驗證速度並最佳化定序工作流程的技術應用。

定序與樣品製備負責人必須採取務實的多層次策略，使技術選擇與營運彈性及科研目標一致。首先，採購團隊應擴展供應商資質標準，納入供應鏈透明度、區域庫存能力以及已記錄的緊急時應對計畫，以減少對單一供應商的依賴，並最大限度地減少驗證中斷。同時，研發和實驗室負責人應優先驗證模組化工作流程，在可行的情況下進行組件級等效性測試，並在不影響資料品質的前提下加快採用替代供應商。

描述一種混合方法研究途徑，該方法整合了相關人員訪談、技術文獻綜合以及交叉檢驗的產品和工作流程映射，以得出可靠的結論。

本分析的研究途徑結合了結構化的原始資訊、有針對性的二手資訊綜合以及嚴格的交叉檢驗。原始資料收集包括對學術界、臨床界和商業領域的實驗室主任、採購負責人和技術負責人進行深度訪談，以了解營運限制、檢驗實踐和技術偏好。這些訪談旨在突顯吞吐量、靈敏度和周轉時間之間的實際權衡，並確定應對供應鏈中斷的切實可行的緩解措施。

總結為什麼將樣品製備視為戰略能力對於確保數據完整性、運行彈性和持續的科學進步至關重要。

總之，次世代定序儀的樣本製備已從一系列獨立的實驗室任務發展成為一個策略性領域，對定序速度、可重複性和結果可解釋性有顯著影響。酵素化學、片段化策略、微流體和自動化等領域的技術進步，不僅拓展了適用於高品質定序的檢體範圍，也使實驗室能夠降低變異性並擴大營運規模。同時，貿易政策的轉變和區域格局的演變，凸顯了多元化供應鏈、本地支援和供應商透明度在營運中的必要性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合微流體平台實現單細胞NGS庫製備自動化，提高通量並減少試劑用量
  • 利用酵素片段化試劑盒簡化DNA脫落過程，提高NGS工作流程的定序均一性
  • 開發一種以微珠為基礎的高通量、可擴展的NGS庫純化和精確片段大小選擇純化系統
  • 實施自動化端到端NGS樣品製備解決方案，以最大限度地減少人為錯誤並縮短週轉時間
  • 新興的基於條碼轉座酶的標籤化方法可用於經濟高效的多重NGS庫構建

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的NGS樣品製備市場

  • 放大套件
    • PCR試劑盒
      • 常規PCR試劑盒
      • 數位PCR試劑盒
      • 定量PCR試劑盒
    • 滾動循環放大
      • 掛鎖探針底座
      • Phi29 基體
  • 碎片化和尺寸選擇
    • 酵素斷裂
      • 基於核酸內切酶
      • 基於轉座酶
    • 機械破碎
      • 生物掠食者
      • 協變數
  • 圖書館準備工具包
    • RNA文庫製備
      • mRNA試劑盒
      • 小RNA試劑盒
      • 總RNA試劑盒
    • 目標文庫構建
      • 遺傳疾病檢測
      • 腫瘤專家組
    • 全基因組文庫構建
      • 無需PCR的試劑盒
      • 標準WGS試劑盒
  • 靶向序列捕獲盒
    • 擴增子富集
      • 多重PCR
      • 單重PCR
    • 雜合反應捕獲
      • 基於數組
      • 基於解決方案

9. 按應用分類的NGS樣品製備市場

  • 表觀遺傳學
    • 亞硫酸氫鹽測序
    • ChIP定序
  • 總體基因體學
    • 16S rRNA測序
    • 霰彈槍式宏基因體學
  • RNA定序
    • miRNA定序
    • mRNA定序
    • 總RNA定序
  • 標靶定序
    • 遺傳性疾病
    • 腫瘤學
    • 藥物基因體學
  • 全基因組定序

第10章 依技術分類的NGS樣品製備市場

  • 以微珠為基礎
    • 磁珠
    • 固相珠
  • 基於酵素的
    • 連接酶
    • 限制性內切酶
    • 轉座酶
  • 微射流
    • 基於液滴的
    • 實驗室晶片
  • 基於PCR的
    • 常規PCR
    • 數位PCR
    • QPCR

11. 依工作流程步驟分類的NGS樣品製備市場

  • 放大
    • PCR擴增
    • 滾動圓圈
  • 集中
    • 擴增子
    • 雜合反應
  • 碎片化
    • 酵素
    • 機械的
  • 圖書館準備
    • RNA製備
    • 目標準備
    • 全基因組定序 (WGS) 製備
  • 定量和品質控制
    • 電泳
    • 螢光分析

第12章：依最終用戶分類的NGS樣品製備市場

  • 學術和政府機構
  • 合約研究組織
  • 診斷實驗室
  • 製藥和生物技術

第13章 各地區NGS樣品製備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的NGS樣品製備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國NGS樣品製備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • Roche Diagnostics International Ltd.
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Promega Corporation
    • Merck KGaA
    • BGI Genomics Co., Ltd.
    • Promega Corporation
    • Sysmex Corporation
    • Novogene Co., Ltd.
Product Code: MRR-9F52358C4167

The NGS Sample Preparation Market is projected to grow by USD 9.45 billion at a CAGR of 16.52% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.78 billion
Estimated Year [2025] USD 3.24 billion
Forecast Year [2032] USD 9.45 billion
CAGR (%) 16.52%

Establishing why optimized sample preparation for next-generation sequencing is a strategic capability that drives data quality, workflow efficiency, and competitive differentiation

Next-generation sequencing sample preparation is the foundational discipline that determines data integrity, turnaround speed, and downstream analytical fidelity across research, clinical, and industrial applications. Over the past decade, incremental improvements in reagents, workflows, and automation have steadily compressed cycle times while expanding the range of applications from targeted panels to whole-genome and metagenomic assays. In this context, sample preparation is no longer a routine upstream task; it is a strategic capability that can materially influence overall throughput, reproducibility, and the cost-efficiency of sequencing programs.

Consequently, laboratories and organizations that invest deliberately in optimized sample preparation protocols-spanning fragmentation, amplification, library preparation, enrichment, and quantification-realize disproportionate gains in data quality and operational resilience. As sequencing platforms continue to diversify and customers demand higher sensitivity and lower input requirements, the role of sample preparation vendors, integrators, and internal process owners gains prominence. This introduction frames the subsequent analysis by emphasizing that strategic choices in reagents, hardware, and workflow design directly shape scientific outcomes and commercial competitiveness.

Explaining the technological, operational, and application-driven shifts that are reshaping sample preparation workflows and supplier priorities across laboratories

The landscape of sample preparation for next-generation sequencing is undergoing several transformative shifts driven by technological innovation, changing end-user demands, and evolving regulatory expectations. Advances in enzyme engineering and chemistry have enabled fragmentation and library-preparation chemistries that work reliably with lower-input, degraded, and archival samples, while microfluidics and droplet-based approaches have brought miniaturization and parallelization to routine workflows. These technological shifts are complemented by a rising emphasis on automation and closed-system solutions that reduce operator variability and accelerate time-to-result, particularly for clinical laboratories seeking to scale diagnostic throughput.

At the same time, the application spectrum is broadening: RNA sequencing applications are moving beyond bulk mRNA profiling into small RNA and total RNA characterization, and targeted enrichment methods are increasingly tailored for oncology, inherited-disease panels, and pharmacogenomics. Epigenetics and metagenomics workflows are benefiting from specialized conversion chemistries and library strategies that preserve biological signal while minimizing artifacts. Moreover, the competitive dynamics among suppliers are shifting as companies prioritize integrated workflow compatibility, service models, and reagent quality assurance. Collectively, these trends are reshaping procurement priorities and accelerating the adoption of modular solutions that can be validated quickly and scaled across heterogeneous lab environments. As a result, organizations must reassess vendor selection criteria, validation timelines, and internal capabilities to capture the benefits of these advances.

Analyzing how US tariff changes and trade policy adjustments in 2025 have increased supply chain friction, procurement complexity, and the prioritization of regional resilience

The cumulative effect of tariff actions and trade policy adjustments in the United States during 2025 has introduced new frictions into global supply chains for sample preparation reagents, plastics, and instrumentation. Elevated import duties and tightened classification requirements have increased landed costs for some hardware components and specialty consumables, prompting procurement teams to revisit supplier diversification, inventory policies, and contractual terms. In parallel, customs compliance has required more granular product coding and documentation, extending lead times for critical items while increasing administrative overhead for both vendors and buyers.

These developments have amplified the operational importance of local distribution partnerships, regional manufacturing footprints, and multi-sourcing strategies. Organizations have responded by prioritizing vendors that maintain regional inventory buffers or that have established manufacturing capacity closer to end markets. In some cases, laboratories have adjusted inventory and ordering cadence to accommodate longer and more volatile lead times, while validation teams have expanded their list of approved equivalencies to reduce single-source risk. Additionally, price negotiation has increasingly factored in total landed cost, including duties and customs-processing expenses, rather than relying solely on list prices.

From a strategic perspective, the tariff-driven environment has accelerated initiatives to simplify supply chains: vendors are consolidating SKUs, offering bundled kits to reduce cross-border transactions, and investing in local service capabilities. For buyers, the imperative is clear-adapt procurement strategies to emphasize supply continuity, contractual flexibility, and vendor transparency. Taken together, these shifts affect capital planning, validation scheduling, and cost-per-assay calculations, and they underscore the importance of supply chain resilience as an integral component of long-term operational planning.

Unpacking a multi-axis segmentation framework that links product types, applications, technologies, workflow steps, and end-user profiles to strategic product and commercialization choices

A coherent segmentation framework reveals the multidimensional nature of the sample preparation landscape and clarifies where innovation and demand are concentrated. When viewed through the lens of product type, the market spans amplification kits, fragmentation and size selection solutions, library preparation kits, and target enrichment kits. Amplification kits encompass conventional PCR approaches as well as digital PCR and qPCR variants, and further include rolling circle amplification with padlock probe and phi29-based methods. Fragmentation and size selection strategies divide into enzymatic fragmentation-distinguishing endonuclease and transposase approaches-and mechanical fragmentation methods such as popular sonication platforms. Library preparation offerings cover RNA-focused workflows (including mRNA, small RNA, and total RNA kits), targeted library approaches for inherited disease and oncology panels, and whole-genome library kits that range from PCR-free to standard WGS preparations. Target enrichment follows a bifurcated path of amplicon-based methods, including multiplex and singleplex PCR, and hybridization-capture strategies that may leverage either array-based or solution-based formats.

Examining segmentation by application further sharpens strategic focus: epigenetics workflows employ bisulfite and ChIP sequencing techniques to interrogate regulatory marks, metagenomics relies on 16S rRNA sequencing and shotgun approaches to profile complex microbial communities, and RNA sequencing spans miRNA, mRNA, and total RNA modalities. Targeted sequencing use-cases emphasize inherited disease, oncology, and pharmacogenomics, reflecting clinical and translational priorities that demand high sensitivity and rigorous validation. Technology segmentation highlights bead-based and enzyme-based chemistries, microfluidic platforms that include droplet and lab-on-chip implementations, and PCR-centric technologies that appear across conventional, digital, and qPCR formats. Finally, evaluating the workflow step perspective clarifies where value is added: amplification, enrichment, fragmentation, library construction, and quantification/quality control each present distinct performance and validation challenges, with quantification increasingly relying on electrophoretic and fluorometric methods. End-user segmentation identifies academic and government research institutions, contract research organizations, diagnostic laboratories, and pharmaceutical and biotechnology companies as the primary adopters, each with different throughput, validation, and procurement requirements.

Taken together, these segmentation layers provide a granular map for product development, go-to-market strategies, and service offerings. They reveal opportunities for suppliers to specialize vertically-for example, by focusing on low-input RNA library chemistry for clinical diagnostics-or to offer modular, validated bundles that reduce buyer validation burden across common workflow steps. This multi-axis view also supports more nuanced commercial conversations with end users, where the intersection of product type, application, and workflow step determines evaluation criteria and procurement timelines.

Exploring how regional supply chain architecture, regulatory regimes, and end-user sophistication shape adoption, support models, and commercialization strategies

Regional dynamics exert a decisive influence on how sample preparation technologies are adopted, regulated, and commercialized. In the Americas, strong academic research capacity and a dense concentration of diagnostic laboratory networks drive demand for both high-throughput automation and specialized kits that support clinical validation. Investment in translational research and a mature private biotech sector incentivize suppliers to provide integrated solutions that ease regulatory submission and laboratory accreditation. In addition, proximity to major manufacturers and regional distribution hubs often shortens lead times and improves after-sales support.

Europe, the Middle East, and Africa display heterogenous adoption patterns driven by differing regulatory regimes, funding models, and healthcare priorities. Western European markets prioritize compliance, reproducibility, and integration with national health systems, motivating suppliers to demonstrate robust quality systems and CE marking or equivalent certifications. Meanwhile, markets across the Middle East and Africa may prioritize cost-effective, ruggedized solutions and localized training and service models. These regional distinctions create opportunities for differentiated go-to-market strategies that account for regulatory complexity, procurement cycles, and local laboratory capacity.

The Asia-Pacific region combines dynamic growth in research infrastructure with rapidly expanding clinical genomics initiatives. Investments in domestic manufacturing and reagent production are notable, driving a mix of locally developed solutions and international partnerships. Differences in regulatory frameworks across countries, varying reimbursement policies, and diverse end-user needs mean that suppliers who can offer adaptable product platforms and local technical support are particularly well-positioned. Across all regions, the overarching theme is that regional supply chain architecture, regulatory expectations, and end-user sophistication jointly shape adoption curves and the design of commercially viable offerings.

Assessing competitive differentiation driven by proprietary chemistries, automation compatibility, service models, and strategic partnerships across the supplier landscape

Competitive dynamics among companies active in sample preparation reflect a balance between deep technical capability, breadth of validated workflows, and the ability to support customers through lifecycle services. Key players differentiate themselves through proprietary chemistries, automation integrations, and quality-control solutions that reduce variability and accelerate validation. Partnerships between reagent providers and instrument manufacturers are increasingly common, yielding bundled solutions that simplify procurement for high-throughput clinical and commercial sequencing labs. At the same time, smaller specialist firms focus on niche chemistries-such as enzyme formulations optimized for low-input or damaged DNA-or on microfluidic systems that enable unique sample handling capabilities.

Investment patterns highlight that companies concentrating on interoperability and open-architecture models can gain traction in environments where buyers prioritize flexibility and vendor neutrality. Conversely, firms that develop closed, fully validated systems appeal to clinical adopters seeking minimal hands-on validation and predictable performance. A further competitive axis centers on service and training: organizations offering on-site method transfer, validation support, and rapid reagent replacement tend to retain higher customer loyalty. Mergers, strategic alliances, and licensing agreements are likely to persist as routes to expand product portfolios and distribution reach, while R&D emphasis on enzyme innovation, low-bias library chemistries, and on-deck automation continues to define technology leadership. In this environment, commercial success depends on a mix of technical excellence, regulatory readiness, and a service-oriented approach that addresses customers' operational constraints.

Prescriptive actions for procurement, R&D, and laboratory leaders to enhance supply resilience, accelerate validation, and optimize technology adoption for sequencing workflows

Leaders in sequencing and sample preparation must adopt a pragmatic, layered strategy that aligns technology choices with operational resilience and scientific objectives. First, procurement teams should expand vendor qualification criteria to include supply chain transparency, regional inventory capabilities, and documented contingency plans, thereby reducing single-source exposure and minimizing validation disruptions. Concurrently, R&D and laboratory directors should prioritize modular workflow validation-opting for component-level equivalency testing where feasible-to accelerate adoption of alternative suppliers without compromising data quality.

Second, invest selectively in automation and closed-system solutions for high-throughput and clinical operations while retaining manual or bench-top flexibility for exploratory and low-volume studies. This hybrid approach balances the throughput and reproducibility gains of automation with the experimental agility needed for method development. Third, cultivate deeper technical partnerships with suppliers that provide co-validation support, method transfer services, and joint training programs; these relationships shorten qualification timelines and improve run-to-run consistency. Fourth, incorporate total landed cost into procurement decision-making, including considerations of tariffs, customs processing, and regional service availability, to ensure commercial decisions reflect operational realities. Finally, create a governance cadence that aligns procurement, compliance, and scientific leadership around validation timelines, change control processes, and inventory policies. Together, these actions enable organizations to maintain scientific rigor, reduce operational risk, and accelerate time-to-insight.

Describing a mixed-methods research approach that integrates stakeholder interviews, technical literature synthesis, and cross-validated product and workflow mapping to ensure robust conclusions

The research approach underpinning this analysis combined structured primary engagement with targeted secondary-source synthesis and rigorous cross-validation. Primary data collection included in-depth interviews with laboratory directors, procurement officers, and technical leads across academic, clinical, and commercial settings to capture operational constraints, validation practices, and technology preferences. These interviews were designed to surface real-world trade-offs between throughput, sensitivity, and hands-on time, and to identify practical mitigation strategies for supply chain disruptions.

Secondary research encompassed technical literature, regulatory guidance, vendor documentation, and publicly available product specifications to map technology features and workflow compatibility. Where possible, product performance characteristics were triangulated across multiple sources to reduce reliance on single-provider claims. The analysis also incorporated case studies of workflow implementations and procurement adaptations to highlight replicable best practices. Data synthesis employed thematic coding to distill recurring challenges and opportunities, and cross-sectional matrices were used to align segmentation layers with end-user requirements.

Limitations are acknowledged: proprietary performance data and unpublished validation studies were not available for all products, and some supplier-specific operational details remain confidential. Nonetheless, the methodology emphasizes reproducibility and transparency, prioritizing observable practices and verifiable documentation while situating findings within broader technological and regulatory trends.

Summarizing why treating sample preparation as a strategic capability is essential for ensuring data integrity, operational resilience, and sustained scientific advancement

In conclusion, sample preparation for next-generation sequencing has evolved from a set of discrete laboratory tasks into a strategic domain that materially affects speed, reproducibility, and the interpretability of sequencing results. Technological advances in enzyme chemistry, fragmentation strategies, microfluidics, and automation are expanding the types of specimens amenable to high-quality sequencing while enabling laboratories to scale operations with reduced variability. Concurrently, trade policy shifts and evolving regional dynamics underscore the operational need for diversified supply chains, regional support, and vendor transparency.

Organizations that proactively align procurement, validation, and scientific strategy will be best positioned to capture the benefits of emerging technologies. Prioritizing multi-sourcing, modular validation, and strategic supplier partnerships can mitigate supply chain risk while preserving scientific flexibility. Ultimately, leaders who treat sample preparation as an integral element of their sequencing strategy-rather than a peripheral commodity-will realize better data quality, faster turnaround, and more reliable outcomes across research and clinical programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of microfluidic platforms for automated single-cell NGS library preparation to enhance throughput and reduce reagent usage
  • 5.2. Adoption of enzymatic fragmentation kits for streamlined DNA shearing and improved sequencing uniformity in NGS workflows
  • 5.3. Development of magnetic bead-based cleanup systems for high-throughput, scalable NGS library purification and precise size selection
  • 5.4. Implementation of robotics-driven end-to-end NGS sample prep solutions to minimize manual error and accelerate turnaround times
  • 5.5. Emergence of barcoded transposase-based tagmentation methods for cost-effective multiplexed NGS library construction

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Sample Preparation Market, by Product Type

  • 8.1. Amplification Kits
    • 8.1.1. Pcr Kits
      • 8.1.1.1. Conventional Pcr Kits
      • 8.1.1.2. Digital Pcr Kits
      • 8.1.1.3. Qpcr Kits
    • 8.1.2. Rolling Circle Amplification
      • 8.1.2.1. Padlock Probe Based
      • 8.1.2.2. Phi29 Based
  • 8.2. Fragmentation And Size Selection
    • 8.2.1. Enzymatic Fragmentation
      • 8.2.1.1. Endonuclease Based
      • 8.2.1.2. Transposase Based
    • 8.2.2. Mechanical Fragmentation
      • 8.2.2.1. Bioruptor
      • 8.2.2.2. Covaris
  • 8.3. Library Prep Kits
    • 8.3.1. Rna Library Prep
      • 8.3.1.1. Mrna Kits
      • 8.3.1.2. Small Rna Kits
      • 8.3.1.3. Total Rna Kits
    • 8.3.2. Targeted Library Prep
      • 8.3.2.1. Inherited Disease Panels
      • 8.3.2.2. Oncology Panels
    • 8.3.3. Whole Genome Library Prep
      • 8.3.3.1. Pcr-free Kits
      • 8.3.3.2. Standard Wgs Kits
  • 8.4. Target Enrichment Kits
    • 8.4.1. Amplicon Enrichment
      • 8.4.1.1. Multiplex Pcr
      • 8.4.1.2. Singleplex Pcr
    • 8.4.2. Hybridization Capture
      • 8.4.2.1. Array Based
      • 8.4.2.2. Solution Based

9. NGS Sample Preparation Market, by Application

  • 9.1. Epigenetics
    • 9.1.1. Bisulfite Sequencing
    • 9.1.2. Chip Sequencing
  • 9.2. Metagenomics
    • 9.2.1. 16s Rrna Sequencing
    • 9.2.2. Shotgun Metagenomics
  • 9.3. Rna Sequencing
    • 9.3.1. Mirna Sequencing
    • 9.3.2. Mrna Sequencing
    • 9.3.3. Total Rna Sequencing
  • 9.4. Targeted Sequencing
    • 9.4.1. Inherited Disease
    • 9.4.2. Oncology
    • 9.4.3. Pharmacogenomics
  • 9.5. Whole Genome Sequencing

10. NGS Sample Preparation Market, by Technology

  • 10.1. Bead Based
    • 10.1.1. Magnetic Beads
    • 10.1.2. Solid Phase Beads
  • 10.2. Enzyme Based
    • 10.2.1. Ligase
    • 10.2.2. Restriction Enzyme
    • 10.2.3. Transposase
  • 10.3. Microfluidics
    • 10.3.1. Droplet Based
    • 10.3.2. Lab On Chip
  • 10.4. Pcr Based
    • 10.4.1. Conventional Pcr
    • 10.4.2. Digital Pcr
    • 10.4.3. Qpcr

11. NGS Sample Preparation Market, by Workflow Step

  • 11.1. Amplification
    • 11.1.1. Pcr Amplification
    • 11.1.2. Rolling Circle
  • 11.2. Enrichment
    • 11.2.1. Amplicon
    • 11.2.2. Hybridization
  • 11.3. Fragmentation
    • 11.3.1. Enzymatic
    • 11.3.2. Mechanical
  • 11.4. Library Preparation
    • 11.4.1. Rna Prep
    • 11.4.2. Targeted Prep
    • 11.4.3. Wgs Prep
  • 11.5. Quantification And QC
    • 11.5.1. Electrophoretic
    • 11.5.2. Fluorometric

12. NGS Sample Preparation Market, by End User

  • 12.1. Academic And Government
  • 12.2. Contract Research Organizations
  • 12.3. Diagnostic Laboratories
  • 12.4. Pharma And Biotech

13. NGS Sample Preparation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. NGS Sample Preparation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. NGS Sample Preparation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Illumina, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. QIAGEN N.V.
    • 16.3.4. Roche Diagnostics International Ltd.
    • 16.3.5. Agilent Technologies, Inc.
    • 16.3.6. New England Biolabs, Inc.
    • 16.3.7. Takara Bio Inc.
    • 16.3.8. PerkinElmer, Inc.
    • 16.3.9. Bio-Rad Laboratories, Inc.
    • 16.3.10. Promega Corporation
    • 16.3.11. Merck KGaA
    • 16.3.12. BGI Genomics Co., Ltd.
    • 16.3.13. Promega Corporation
    • 16.3.14. Sysmex Corporation
    • 16.3.15. Novogene Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW STEP, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW STEP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NGS SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NGS SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NGS SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NGS SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLIFICATION KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CONVENTIONAL PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY DIGITAL PCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY QPCR KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PADLOCK PROBE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PHI29 BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY FRAGMENTATION AND SIZE SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENZYMATIC FRAGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ENDONUCLEASE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TRANSPOSASE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MECHANICAL FRAGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BIORUPTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY COVARIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREP KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY PREP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SMALL RNA KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED LIBRARY PREP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY INHERITED DISEASE PANELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY PANELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME LIBRARY PREP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY PCR-FREE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY STANDARD WGS KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY AMPLICON ENRICHMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SINGLEPLEX PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY HYBRIDIZATION CAPTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY ARRAY BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SOLUTION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY EPIGENETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY BISULFITE SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY SHOTGUN METAGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MIRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY MRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TOTAL RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL NGS SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL NGS SAMPLE PREPARATION MAR